Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients
Immunology Letters · 2025
DOI: 10.1016/j.imlet.2024.106962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2025. Verfasst von Francesca La Gualana und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Monoclonal, Humanized, T-Box Domain Proteins, B-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, NextGenerationEU, European Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
- Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome.
- Lupus Clinic, Rheumatology, Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Viale del Policlinico 155 00161 Rome, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, Medical School, University of Pisa, Pisa, Italy.
- Department of Clinical Pathology, Santa Maria Goretti HospitalAUSL Latina, Latina, Italy.
- Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. Electronic address: marcella.visentini@uniroma1.it.
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- NextGenerationEU
- European Commission
- Sapienza Università di Roma
Zitieren
APA
La Gualana, F., Olivieri, G., Petriti, B., Picciariello, L., Natalucci, F., Sciannamea, M., Gragnani, L., Basile, U., Casato, M., Spinelli, F. R., Stefanini, L., Basili, S., Visentini, M., Ceccarelli, F., & Conti, F. (2025). Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106962
Vancouver
La Gualana F, Olivieri G, Petriti B, Picciariello L, Natalucci F, Sciannamea M, et al. Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients. Immunology Letters. 2025. doi:10.1016/j.imlet.2024.106962
BibTeX
@article{LaGualana2025,
author = {La Gualana, Francesca and Olivieri, Giulio and Petriti, Begi and Picciariello, Licia and Natalucci, Francesco and Sciannamea, Maddalena and Gragnani, Laura and Basile, Umberto and Casato, Milvia and Spinelli, Francesca Romana and Stefanini, Lucia and Basili, Stefania and Visentini, Marcella and Ceccarelli, Fulvia and Conti, Fabrizio},
title = {Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients},
journal = {Immunology Letters},
year = {2025},
doi = {10.1016/j.imlet.2024.106962}
}
EUVIMED